Sylvia Health 2022 – 2023

Our innovative device provides targeted support to correct vaginal bulging, offering a non-surgical alternative for women who can’t have, don’t want or are waiting for surgery.

This supportive device addresses pessary limitations, providing quality of life and empowerment for users, and clinical and cost effective treatment for healthcare providers. We’re determined to make something that actually works, so our medical grade prototypes are currently undergoing rigourous testing by women with prolapse. 

The problem we are addressing

Pelvic organ prolapse occurs when one or more of the organs in the female pelvis descend into, or out of, the vagina. This condition not only leads to pain and discomfort but also imposes significant mental and emotional challenges, hindering women’s ability to fully engage in work, social activities, and family life.
1 in 12 women experience symptomatic prolapse – over 200 million women worldwide. Due to stigma and underreporting, the actual number is likely even higher, and prolapse incidence is growing. In the US alone it is projected to increase by 46% by 2050.

Despite its widespread prevalence and debilitating effects, prolapse often goes overlooked, and current treatment options frequently fall short.  Surgery entails a painful recovery, prolonged lifting restrictions, a high likelihood of requiring additional procedures, and facing lengthy waiting lists. Half of women who use a pessary discontinue within 3-12 months – most often due to expulsion, erosion, discomfort & inefficiency. 

Discovery process

During our time at BioMedical Design we had four months of clinical observations at the obstetrics and gynaecology departments of Slagelse Hospital. We encountered many problems within women’s health, and witnessed the profound impact of pelvic organ prolapse on women’s lives. 

The scale and impact of prolapse shocked us, sparking a deepening interest that persisted throughout the programme. We met with and interviewed patients and clinicians from six countries, delving into disease fundamentals, prevalence, risk factors, stigma, and treatment options. Our immersion led us to a resolute belief that women deserve superior treatment options and that we could be the catalyst for change. 

The team